Recent genome- and exome-wide association studies suggest that the human APOE ε4 allele protects against non-alcoholic fatty liver disease (NAFLD), while ε3 promotes hepatic steatosis and steatohepatitis. The gene discussed is APOE; the disease is metabolic dysfunction-associated steatotic liver disease.